Business
Marizyme Announces Expansion of Patent Portfolio Into Several Key Territories
Marizyme Announces Expansion of Patent Portfolio Into Several Key Territories.
About this update from Marizyme, Inc.
[{"type":"text","content":"\n Jupiter, FL, Dec. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Marizyme Inc. (MRZM), a biotechnology company engaged in the development and commercialization of advanced healthcare products to prevent, treat and diagnose diseases of unmet clinical need, announced today that it has received notice of allowance for foundational patent applications for two of its core technologies in several key markets further strengthening the company’s intellectual property. Marizyme also announced today that it has retained the services of Dentons US LLP, the world’s largest law firm with more than 600 international patent lawyers and professionals in more than 80 countries, to manage its global patent portfolio.  Patent applications covering the company’s flagship commercial product, DuraGraft®,have been allowed in Brazil, China and Malaysia. The allowed DuraGraft® related patent applications cover an organ and tissue preservation kit containing shelf-life stable solutions used for vascular graft and tissue protection and preservation during bypass and other vascular surgeries. These patents protect Marizyme’s flagship commercial product DuraGraft®, a first-in-class CE marked intra-operative graft storage solution. DuraGraft® protects vascular grafts against ischemic injury during bypass surgeries by reducing the incidence of complications associated with vein graft failure, leading to improved clinical outcomes. DuraGraft®is the only product approved for graft protection and preservation during bypass and other vascular surgeries. “Brazil and China represent large and rapidly expanding cardiac surgery markets and the allowances in these countries expand our patent estate for DuraGraft and present tremendous commercialization and licensing opportunities for us,” said David Barthel, Marizyme’s CEO. “Additionally, Malaysia represents a key territory in Asia Pacific in which we already have a significant customer base.” The DuraGraft patent portfolio includes granted patents and pending applications in over 30 countries throughout the world, including patents granted in Europe, Australia, Argentina, South Africa, Mexico, and several Asian countries, and pending applications in the US and other countries. Additionally, a patent application cov...